Arcanobacterium haemolyticum: Difference between revisions

From IDWiki
Arcanobacterium haemolyticum
(Created page with "{{DISPLAYTITLE:''Arcanobacterium haemolyticum''}} == Background == * Non-motile beta-hemolytic, Stain::Gram-positive Cellular shape::bacillus == Clinical Manifestat...")
 
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{DISPLAYTITLE:''Arcanobacterium haemolyticum''}}

== Background ==
== Background ==


* Non-motile beta-hemolytic, [[Stain::Gram-positive]] [[Cellular shape::bacillus]]
* Non-motile beta-hemolytic, [[Stain::Gram-positive]] [[Shape::curved]] [[Shape::bacillus]]
* May be [[Stain::Gram-variable]]
* Previously known as [[Corynebacterium haemolyticum]]


== Clinical Manifestations ==
== Clinical Manifestations ==


* Most commonly causes [[pharyngitis]], but can also cause [[meningitis]], [[pneumonia]], [[brain abscess]], [[osteomyelitis]], and [[peritonsillar abscess]]
* Most commonly causes [[pharyngitis]], particularly in children and young adults
** May have diphtheria-like tonsillar exudates
* Rash in 25-50%, which may be urticarial, macular, or maculopapular
** Rash in 25-50%, which may be urticarial, macular, or maculopapular
** Typically on trunk and extremities, and spares the palms, soles, and face
*** Typically on trunk and extremities, and spares the palms, soles, and face
* Next most common is [[skin and soft tissue infection]], usually polymicrobial
* Also a case-reportable cause of [[meningitis]], [[pneumonia]], [[brain abscess]], [[osteomyelitis]], and [[peritonsillar abscess]]


== Management ==
== Management ==


* Susceptible to most antibiotics, including [[penicillins]], [[cephalosporins]], [[carbapenems]], [[tetracyclines]], [[macrolides]], [[lincosamides]], and [[vancomycin]]
* First-line antibiotic is [[Is treated by::erythromycin]] due to increasing [[penicillin]] resistance
* Not reliably susceptible to [[co-trimoxazole]]


{{DISPLAYTITLE:''Arcanobacterium haemolyticum''}}
[[Category:Gram-positive bacilli]]
[[Category:Gram-positive bacilli]]

Latest revision as of 17:07, 13 February 2024

Background

Clinical Manifestations

Management